Keyphrases
Nave
54%
Minimal Change Disease
54%
Hepatitis C
54%
Fibroblast Growth Factor 23 (FGF23)
54%
Acute Interstitial Nephritis
54%
Chronic Kidney Disease
54%
Infectious Mononucleosis
54%
Acute Kidney Injury
54%
Renal Replacement Therapy
54%
Database Analysis
54%
Continuous Renal Replacement Therapy
54%
Injury Factors
54%
MarketScan
54%
Acute Renal Failure
45%
Intermittent Hemodialysis
40%
Renal Failure
31%
Hemodialysis
31%
Epstein-Barr Virus Infections
27%
Renal Involvement
27%
End-stage Renal Disease
27%
Hepatitis C Virus Infection
18%
Middle-aged
18%
Glomerular Disease
18%
African American
18%
Urethral Stricture
18%
Reflux Nephropathy
18%
Membranoproliferative Glomerulonephritis
18%
Massive Proteinuria
18%
Focal Segmental Glomerulosclerosis
18%
Laboratory Evaluation
18%
Proteinuria
18%
Nephrotic Syndrome
18%
African American Men
18%
Renal Biopsy
18%
High-dose Steroids
18%
Chronic Kidney Disease Patients
14%
Phosphorus
14%
Serum Phosphorus
14%
Corticosteroids
13%
Self-limiting
13%
Review Literature
13%
Renal Function
13%
Renal Manifestations
13%
At Discharge
13%
Chronic Kidney Disease Stage
9%
Modification of Diet in Renal Disease
9%
Estimated Glomerular Filtration Rate
9%
Critically Ill Patients
6%
Renal Recovery
6%
Logistic Regression
6%
Medicine and Dentistry
Acute Kidney Injury
100%
Hemodialysis
72%
Phosphate Binder
54%
Hepatitis C
54%
Interstitial Nephritis
54%
Continuous Renal Replacement Therapy
54%
Renal Replacement Therapy
54%
Proteinuria
36%
Renal Failure
31%
Epstein-Barr Virus Infection
27%
End Stage Renal Disease
27%
Kidney Function
20%
Nephrotic Syndrome
18%
Middle Age
18%
Focal Segmental Glomerulosclerosis
18%
Prevalence
18%
Disease
18%
Infection
18%
Renal Biopsy
18%
Glomerulopathy
18%
Differential Diagnosis
18%
Drug Megadose
18%
Sevelamer Carbonate
14%
ICD-10
6%
Kidney Injury
6%
Retrospective Cohort Study
6%
Logistic Regression Analysis
6%